newsfilter
← Latest News
GlobeNewswire·

Amryt to Report FY and Q4 2021 Results on March 9, 2022

Amryt to Report FY and Q4 2021 Results on March 9, 2022 DUBLIN, Ireland, and Boston MA, February 23, 2022, Amryt (NASDAQ:AMYT) a global, commercial-stage biopharmaceutical company dedicated to acquiring, developing and commercializing novel treatm